SIGMAR1 and Alzheimer disease: Studies also demonstrated that Sigmar1 ligands (e.g., OZP002, donepezil, ANAVEX2-73) prevented toxicity and memory impairment in pharmacologic and genetic mouse models of AD (Maurice et al., 2019; Ryskamp et al., 2019).